

Reciprocating Cylinder Dissolution Tester (USP Apparatus 3)
往复筒溶出度仪(USP 装置 3)
- SKU TDT-0004
- Tablet Dissolution Testers
- CE (to be confirmed)
- ISO 9001 manufacturing (to be confirmed)
Price on request — FOB / CIF quoted per order
Prices depend on configuration, quantity and destination port.
Key specifications
| Apparatus type | USP Apparatus 3 (reciprocating cylinder) |
|---|---|
| Number of stations | 6 or 7 columns |
| Vessel volume | 100–300 mL |
| Dip rate | 5–40 dips/min |
| Stroke length | 10 cm nominal |
| Temperature range | ambient +5 to 45 °C |
By Lab Manufacturers China Technical TeamLast reviewed Standards: USP <711>, USP <1092>, Ph. Eur. 2.9.3
What is the Reciprocating Cylinder Dissolution Tester (USP Apparatus 3)?
A reciprocating cylinder dissolution tester operates USP Apparatus 3, dipping the dosage form in a glass tube with mesh ends up and down through a series of media. It is used for extended-release products that need pH-gradient or multi-stage release profiling.
What is the Reciprocating Cylinder Dissolution Tester (USP Apparatus 3)?
A reciprocating cylinder dissolution tester operates USP Apparatus 3, dipping the dosage form in a glass tube with mesh ends up and down through a series of media. It is used for extended-release products that need pH-gradient or multi-stage release profiling.
Overview
USP Apparatus 3 places the tablet in an inner glass cylinder with screens on both ends, which reciprocates vertically inside an outer flat- or round-bottom vessel at typically 5–40 dips per minute. A row of vessels, often six, holds different media, and the sample holders can be transferred automatically from one column to the next according to a programmed schedule. This lets analysts move a dosage form from gastric to intestinal pH without handling it, simulating the gastrointestinal transit profile. The hydrodynamics are gentler and more controllable than paddles, which benefits beaded products, chewables and extended-release matrices prone to coning. Sampling is taken at the end of each interval, either manually or with a multi-port autosampler. The instrument is more complex mechanically than Apparatus 1/2 and requires calibration of dip rate, stroke length and screen mesh size.
How does it work?
A dissolution tester places the dosage form in a vessel of temperature-controlled medium, usually 500–1000 mL of buffer or acid, and agitates it by a rotating basket (Apparatus 1), paddle (Apparatus 2), reciprocating cylinder (Apparatus 3) or flow of medium (Apparatus 4). Aliquots are withdrawn at specified times through filters and assayed by UV-Vis or HPLC. The key components are a thermostatted water bath or waterless heater, a drive head holding shaft speed within ±2 rpm, polished glass or plastic vessels of defined geometry, and calibrated shafts with minimal wobble. Hydrodynamics, shaft position, centering and vibration all influence results, so mechanical qualification is integral. Drug release follows Noyes–Whitney kinetics, where dissolution rate depends on surface area, solubility and boundary layer thickness, and sink conditions must be maintained so that the medium volume is at least three times the saturation volume.
What are the key features?
- Programmable transfer of sample holders between media columns
- Dip rate adjustable from about 5 to 40 dips per minute
- Suitable for pH-gradient and multi-stage release profiling
- Gentle hydrodynamics for beads, chewables and extended-release matrices
- Stroke length set at 9.9–10.1 cm for compendial compliance
- Removable screens in 10–840 µm mesh sizes
What are the technical specifications?
A typical reciprocating cylinder dissolution tester (usp apparatus 3) configuration offers apparatus type of USP Apparatus 3 (reciprocating cylinder), number of stations of 6 or 7 columns, vessel volume of 100–300 mL, dip rate of 5–40 dips/min, stroke length of 10 cm nominal and temperature range of ambient +5 to 45 °C. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.
Which applications is it used for?
The Reciprocating Cylinder Dissolution Tester (USP Apparatus 3) is used in extended-release tablet profiling, beaded capsule dissolution, GI transit simulation and chewable tablet testing. Across the wider Tablet Dissolution Testers class, laboratories also deploy it for pharmaceutical QC, generic drug bioequivalence support and formulation development.
Which standards and certifications apply?
Relevant standards and methods include USP <711>, USP <1092>, Ph. Eur. 2.9.3, JP 6.10, ChP 0931, USP <724>, ASTM E2503 and FDA Guidance on Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Certification candidates for this model are CE and ISO 9001 manufacturing; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.
Place the tester on a vibration-free bench, level it, and keep it away from air currents and centrifuges. Perform mechanical calibration of shaft wobble, vessel centering, verticality, speed and temperature at installation and at regular intervals, and run performance verification with USP prednisone or salicylic acid calibrator tablets. Degas media to prevent bubbles, clean vessels after each run, inspect shafts and baskets for corrosion or damage, and replace filters per SOP. Documentation should cover IQ/OQ/PQ, calibration records, and data-integrity controls.
How do I select the right Reciprocating Cylinder Dissolution Tester (USP Apparatus 3)?
Select Apparatus 3 when the monograph or development plan requires it, or when a dosage form must pass through media of changing pH. Specify the number of columns, vessel volume, mesh sizes, and whether automated transfer and sampling is required. For immediate-release routine QC, Apparatus 1/2 is simpler and cheaper.
How does it compare with other Tablet Dissolution Testers variants?
Start with the apparatus type the monograph specifies: Apparatus 1 or 2 for most immediate-release products, Apparatus 3 for extended-release and pH-shift profiling, Apparatus 5 or 6 for patches. Then choose vessel count by throughput: six for routine QC, eight for batches with standards, and automated systems for unattended profiles. Consider temperature control (bath versus waterless), speed range and accuracy, and compatibility with an autosampler or UV interface. For regulated sites, require IQ/OQ documentation, mechanical calibration fixtures, and software with audit trail. Also check vessel volume range, because low-dose or poorly soluble products may need 100–250 mL mini-vessels or 2–4 L vessels.
Full specifications
| Apparatus type | USP Apparatus 3 (reciprocating cylinder) |
|---|---|
| Number of stations | 6 or 7 columns |
| Vessel volume | 100–300 mL |
| Dip rate | 5–40 dips/min |
| Stroke length | 10 cm nominal |
| Temperature range | ambient +5 to 45 °C |
| Temperature stability | ±0.5 °C |
| Screen mesh size | 10–840 µm |
| Transfer programming | up to 99 steps |
| Power supply | 220 V AC, 50/60 Hz, about 1.0 kW |
Indicative values for this product class. Final specifications are confirmed on the quotation and in the calibration documents supplied with the instrument.
Applications
- Extended-release tablet profiling
- Beaded capsule dissolution
- GI transit simulation
- Chewable tablet testing
Key features
- Programmable transfer of sample holders between media columns
- Dip rate adjustable from about 5 to 40 dips per minute
- Suitable for pH-gradient and multi-stage release profiling
- Gentle hydrodynamics for beads, chewables and extended-release matrices
- Stroke length set at 9.9–10.1 cm for compendial compliance
- Removable screens in 10–840 µm mesh sizes
Frequently asked questions about Reciprocating Cylinder Dissolution Tester (USP Apparatus 3)
Apparatus 3 is specified in some extended-release and beaded-product monographs and is preferred when a release profile across multiple pH stages is required. It is also useful for forms that cone or float in paddle tests.
Typical vessel volumes are 100 to 300 mL, much smaller than the 900 mL used in Apparatus 2. Small volumes can limit sink conditions for poorly soluble drugs, so solubility must be checked.
Yes. The holder moves from an acidic medium column to buffered columns at preset times, so gastric-to-intestinal transit can be modelled in one continuous run without handling the dosage form.
It measures the amount of active ingredient released from a tablet or capsule into a medium over time under controlled temperature and agitation. Results are compared with monograph limits to confirm batch consistency and predict in vivo release behavior.
Follow the monograph. Apparatus 2 (paddle) suits most tablets, while Apparatus 1 (basket) is used for capsules and dosage forms that float. Both can run on a standard six-vessel tester by exchanging shaft attachments.
Dissolved air forms bubbles on the tablet, baskets and vessel walls during the test, which alters hydrodynamics and lowers apparent dissolution. Degassing by heat, filtration and vacuum, or helium sparging is required by USP <711> unless validated otherwise.
Related models





